An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II

Joseph Muenzer

University of North Carolina School of Medicine, Chapel Hill

Barbara K. Burton

Ann and Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Chicago

Paul Harmatz

UCSF Benioff Children’s Hospital Oakland, Oakland, CA

Deepa S. Rajan

UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh

Simon A. Jones

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

Johanna M.P. van den Hout

Erasmus University Medical Center, Rotterdam, the Netherlands

John J. Mitchell

Montreal Children’s Hospital, McGill University Health Centre, Montreal

Akhil Bhalla

Denali Therapeutics, South San Francisco, CA

Natalie J. Engmann

Denali Therapeutics, South San Francisco, CA

Imanol Zubizarreta

Denali Therapeutics, South San Francisco, CA

Wei Dong

Hangzhou Institute of Medicine Chinese Academy of Sciences

Fabian Model

Denali Therapeutics, South San Francisco, CA

Ryan J. Watts

Denali Therapeutics, South San Francisco, CA

Matthew D. Troyer

Denali Therapeutics, South San Francisco, CA

Peter S. Chin

Denali Therapeutics, South San Francisco, CA

Carole Ho